CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 53 filers reported holding CIDARA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,101,676 | -14.4% | 3,291,950 | +2.7% | 0.00% | – |
Q2 2023 | $3,623,478 | -11.0% | 3,206,618 | 0.0% | 0.00% | – |
Q1 2023 | $4,072,405 | +118.1% | 3,206,618 | +29.9% | 0.00% | – |
Q4 2022 | $1,867,418 | +20.5% | 2,469,150 | +0.0% | 0.00% | – |
Q3 2022 | $1,550,000 | +28.8% | 2,467,933 | +0.3% | 0.00% | – |
Q2 2022 | $1,203,000 | -41.3% | 2,461,633 | 0.0% | 0.00% | – |
Q1 2022 | $2,050,000 | -34.8% | 2,461,633 | -0.6% | 0.00% | – |
Q4 2021 | $3,146,000 | -29.4% | 2,476,970 | +24.4% | 0.00% | – |
Q3 2021 | $4,458,000 | +11.1% | 1,990,369 | +0.2% | 0.00% | – |
Q2 2021 | $4,013,000 | -29.5% | 1,986,440 | -7.2% | 0.00% | – |
Q1 2021 | $5,695,000 | +49.8% | 2,141,127 | +12.7% | 0.00% | – |
Q4 2020 | $3,801,000 | -49.2% | 1,900,165 | -27.7% | 0.00% | – |
Q3 2020 | $7,489,000 | +20.9% | 2,627,401 | +56.6% | 0.00% | – |
Q2 2020 | $6,192,000 | +97.6% | 1,677,947 | +32.8% | 0.00% | – |
Q1 2020 | $3,133,000 | +20.1% | 1,263,279 | +86.0% | 0.00% | – |
Q4 2019 | $2,608,000 | +92.5% | 679,085 | 0.0% | 0.00% | – |
Q3 2019 | $1,355,000 | +12.4% | 679,085 | -5.4% | 0.00% | – |
Q2 2019 | $1,206,000 | -52.9% | 717,631 | -25.7% | 0.00% | – |
Q1 2019 | $2,561,000 | +25.9% | 966,340 | +11.6% | 0.00% | – |
Q4 2018 | $2,034,000 | -30.0% | 865,734 | +31.1% | 0.00% | – |
Q3 2018 | $2,906,000 | -2.7% | 660,485 | +15.0% | 0.00% | – |
Q2 2018 | $2,987,000 | +32.2% | 574,506 | +1.7% | 0.00% | – |
Q1 2018 | $2,260,000 | -41.2% | 565,106 | -0.1% | 0.00% | – |
Q4 2017 | $3,846,000 | -14.1% | 565,665 | +2.3% | 0.00% | – |
Q3 2017 | $4,478,000 | +98.7% | 552,778 | +83.9% | 0.00% | – |
Q2 2017 | $2,254,000 | -15.8% | 300,547 | -12.4% | 0.00% | – |
Q1 2017 | $2,677,000 | -22.6% | 343,184 | +3.2% | 0.00% | – |
Q4 2016 | $3,457,000 | +62.7% | 332,472 | +79.2% | 0.00% | – |
Q3 2016 | $2,125,000 | +19.7% | 185,575 | +7.7% | 0.00% | – |
Q2 2016 | $1,776,000 | -13.8% | 172,233 | +6.2% | 0.00% | – |
Q1 2016 | $2,061,000 | -10.7% | 162,252 | +20.6% | 0.00% | – |
Q4 2015 | $2,309,000 | -98.6% | 134,541 | -97.1% | 0.00% | -100.0% |
Q3 2015 | $166,079,000 | +13625.5% | 4,677,924 | +5323.9% | 0.01% | – |
Q2 2015 | $1,210,000 | – | 86,246 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
Prosight Management, LP | 245,764 | $578,000 | 0.30% |